Johannes Voshol
6PUBLICATIONS
83CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 24, 2024
Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers.Stephane Ferretti, Jacques Hamon, Ruben de Kanter
|Nov 07, 2023
CRISPR Screening Identifies Mechanisms of Resistance to KRASG12C and SHP2 Inhibitor Combinations in Non-Small Cell Lung Cancer.Anirudh Prahallad, Andreas Weiss, Hans Voshol
|Nov 18, 2022
JDQ443, a Structurally Novel, Pyrazole-Based, Covalent Inhibitor of KRASG12C for the Treatment of Solid Tumors.Edwige Lorthiois, Marc Gerspacher, Kim S Beyer
|Apr 11, 2022
Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12C.Andreas Weiss, Edwige Lorthiois, Louise Barys
|Apr 27, 2021
PAX8 and MECOM are interaction partners driving ovarian cancer.Melusine Bleu, Fanny Mermet-Meillon, Verena Apfel
Pageof 1
Frequent Collaborators
2 joint publications
Kim S Beyer
2 joint publications
Claudio Bomio-Confaglia
2 joint publications
Ruben de Kanter
2 joint publications
Carmine Fedele
2 joint publications
Simona Cotesta
2 joint publications
Rainer Wilcken
2 joint publications
Nils Ostermann
2 joint publications
Johannes Ottl
2 joint publications
Andrea Vaupel
2 joint publications
Rowan Stringer